Loading...

Notice

Check the various announcements of oncoMASTER.

Notice

There are a total of 10 articles.

Number Title Posting Date
44 [oncoMASTER press release] “Yuhan Corporation adds anticancer drug partner…invests KRW 2 billion in oncoMASTER” (2022. 08. 20. Daily Farm) 07/02/2024 14:45
43 [oncoMASTER press release] “Korea University Medical Center and Yonsei University Medical Center join forces to commercialize healthcare technology” (2022. 06. 08. Korea Economic Daily TV) 07/02/2024 14:43
42 [oncoMASTER press release] “[University hospital startup ‘craze’] Over 100 ‘Big 5’ hospitals, including Seoul, Asan, and St. Mary’s… Breaking the taboo on startups ①” (2022. 04. 28. Korea Economic Daily TV) 07/02/2024 14:42
41 [oncoMASTER press release] “Benefit expansion tailwind in full swing… High growth of pharmaceutical companies with sales capabilities” (Medical Times, November 21, 2022) 07/02/2024 14:42
40 [oncoMASTER press release] "Yuhan 3.3 billion, Chong Kun Dang 2 billion, Hanmi 1.9 billion... external investment active" (2022. 08. 23. Daily Farm) 07/02/2024 14:41
39 [oncoMASTER Press Release] “Korea Medical Center participates in the US-KOREA Conference… Subsidiary New Live placed 3rd” (2022. 09. 01. Medical Newspaper) 07/02/2024 14:41
38 [oncoMASTER Director's press release] "Relaxation of university shareholding ratio, development of medical school professor-pharmaceutical cooperation ecosystem" (2022. 09. 22. Medical Times) 07/02/2024 14:39
37 [oncoMASTER Director's press release] "The Asian Oncology Society, led by Korea, China, and Japan, is challenging cancer diagnosis and treatment led by the U.S. and Europe. The Asian Oncology Society is in full swing... A paradigm shift from 'passive → active'" (2022. 06) 17. Daily Medi) 07/02/2024 14:37
36 [oncoMASTER Director press release] “Cancer precision medicine platform oncoMASTER CEO Kim Yeol-hong” (2022. 08. 01. Medical Times Meta Lounge) 07/02/2024 14:37
35 [oncoMASTER Director's press release] "Targeted treatment for lung cancer that has emerged up to the third generation, effective against resistance and brain metastasis" (July 20, 2022, Magazine Environment) 07/02/2024 14:36

oncoMASTER Co., Ltd.

Business registration number: 108-87-02074 | CEO: Wooyoung Jang

Address: #305, Biz S Bldg, Seoul Biohub,117-3 Hoegiro, Seoul, 02455, ROK

Email: contact@oncomaster.co.kr

Copyright 2023. oncoMASTER all rights reserved.

온코마스터 로고.